Comparison

Ticlopidine-d4 (hydrochloride) European Partner

Item no. HY-B0153AS-1ea
Manufacturer MedChem Express
Amount 1 ea
Quantity options 1 ea 1 mg 5 mg
Category
Type Molecules
Specific against other
Citations [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Thebault JJ, et al. Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clin Pharmacol Ther. 1975 Oct;18(4):485-90.|[3]Ashida SI, et al. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Thromb Haemost. 1979 Apr 23;41(2):436-49.
Smiles ClC1=C(CN2CC3=C(CC2)SC=C3)C([2H])=C([2H])C([2H])=C1[2H].Cl
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Isotope-Labeled Compounds
Manufacturer - Targets
Adenosine Receptor; Isotope-Labeled Compounds
Shipping Temperature
Room temperature
Molecular Weight
304.27
Product Description
Ticlopidine-d4 (hydrochloride) is the deuterium labeled Ticlopidine hydrochloride. Ticlopidine hydrochloride is an adenosine diphosphate (ADP) receptor inhibitor against platelet aggregation with IC50 of ~2 μM.
Manufacturer - Research Area
Cardiovascular Disease
Solubility
10 mM in DMSO
Manufacturer - Pathway
GPCR/G Protein; Others
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close